Asst Minister for Health and Aged Care joins a stellar line-up of speakers at Private Cancer Physicians of Australia’s annual Scientific Meeting
Media release: Embargoed until Friday July 08, 2022
Canberra: More than 200 cancer consultants and trainees, patient advocates and healthcare professionals from the private hospital and pharmaceutical sectors will come together for the first time in three years, for the much-anticipated Private Cancer Physicians of Australia’s (PCPA) Scientific Meeting and Medical Oncology and Haematology Advanced Trainee Conference in Melbourne on Saturday July 30 and Sunday July 31, 2022.
The new Assistant Minister for Health and Aged Care, the Hon Ged Kearney MP, will open the conference and outline the Albanese Government’s first term health agenda.
Delegates will also hear from leading oncology and healthcare experts on the latest developments in patient-centred care in medical oncology and haematology and on topics as diverse as optimising Telehealth in cancer care, Voluntary Assisted Dying in Victoria – 2 years later, unpacking the complexities of Medicare and billing, how pharma, patients and cancer specialists are collaborating on access to vital medicines, the role of genomics and genetics in cancer treatment, oncologists in private hospitals and why communications matter: a patient’s perspective.
The President of the PCPA, Associate Professor Christopher Steer, said his board and members are eager to meet face-to-face after such an exhausting and stressful two and a half years.
“The pandemic has been particularly hard for Australians with cancer and those who care for them,” A/Prof Steer said. “We know that the focus has rightly been on protecting patients as much as we can from this terrible global health scourge and, whilst it’s not over yet, we can take a moment to come together and hear from some extraordinary cancer care experts and leaders in patient advocacy.”
A/Prof Steer said that, for the first time, the annual PCPA Scientific Meeting with the Advanced Trainee Conference would be combined – allowing young medical oncologists, radiation oncologists and haematologists to learn from the experts, meet face-to-face and network with their more established consultant colleagues. A/Prof Steer will be the co-convenor with Dr Cam McLaren (medical oncology) and Professor Miles Prince (haematology).
Delegates will also have the opportunity to meet leaders from private hospitals, including Icon Cancer Centre, Ramsay Health Care and GenesisCare (all Silver sponsors) and hear first-hand from oncology-specialist pharmaceutical companies, who will share insights into new treatments, clinical trials and the development of unique medicine-access platforms for patients and their oncologists.
Roche is the 2022 Platinum sponsor for the event. Arrotex, Takeda and Gilead share equal billing as Gold sponsors and the Silver sponsors include esteemed organisations, such as Ipsen, Bristol Myers Squibb, Eisai and Servier Oncology. They are also joined by PCPA’s legal partners Fletcher|Clarendon and business advisors, the Private Practice.
Some of the Silver sponsors will come together on a panel ‘Beyond and Together’ to discuss the challenges and opportunities that lie ahead for cancer care in Australia.
“We are so incredibly excited and humbled to have so many experienced, knowledgeable and respected speakers address our members and guests on issues that go to the very heart of what it means to be a cohesive, collaborative and world class cancer care community,” A/Prof Steer said.
The programs for the Scientific Meeting and the Advanced Trainee (medical oncology and haematology) conference can be found here
Jannette Cotterell. Executive Counsel Australia email@example.com
Mobile: 0419 204 059
NB: Assoc Professor Steer is a practicing regional-based oncologist and may not be available at all times
About the Private Cancer Physicians of Australia
The Private Cancer Physicians of Australia (PCPA) is a not-for-profit organisation dedicated to the improvement of the health system for all cancer patients, but particularly for private cancer patients in Australia.
Our mission is to promote and work towards a health system that provides high quality, fair, integrated cancer treatment
Private Cancer Physicians of Australia’s (PCPA) Scientific Meeting and Medical Oncology and Haematology Advanced Trainee Conference